Suppr超能文献

血浆安替比林半衰期可根据尿液数据来确定。

Plasma antipyrine half-life can be determined from urine data.

作者信息

Atiba J O, Taylor G, Pershe R A, Blaschke T F

出版信息

Br J Clin Pharmacol. 1987 Jun;23(6):715-9. doi: 10.1111/j.1365-2125.1987.tb03106.x.

Abstract

Antipyrine half-life has been determined from measurements of antipyrine concentrations in spontaneously voided urine specimens in eleven subjects, studied on a total of forty-seven different occasions while receiving no drugs, interferon or ketoconazole. Plasma and saliva half-lives show good intrasubject correlation. Plasma and urine half-lives show good intrasubject correlation provided total urine output is at least 1.1 l day-1. The range of intrasubject correlation coefficients for plasma and urinary half-lives was 0.76 to 0.98, with a median value of 0.85. Saliva and urine half-lives show good intrasubject correlation, with the range of intrasubject correlation coefficients from 0.74 to 0.98, and with a median value of 0.75. There is a small but consistent bias towards shorter urinary half-life estimates; this averaged 0.75 h for the plasma-urine studies and 0.192 h for the saliva-urine studies. There were parallel changes in antipyrine half-life estimated from plasma and urine for one of our subjects who received multiple doses of recombinant beta-interferon and had a 150% increase in antipyrine half-life over the study period.

摘要

在11名受试者中,通过测量自发排尿样本中的安替比林浓度来确定安替比林半衰期。这些受试者在总共47个不同时间段内未服用任何药物、干扰素或酮康唑。血浆和唾液半衰期在个体内显示出良好的相关性。如果每日总尿量至少为1.1升,血浆和尿液半衰期在个体内也显示出良好的相关性。血浆和尿液半衰期的个体内相关系数范围为0.76至0.98,中位数为0.85。唾液和尿液半衰期在个体内显示出良好的相关性,个体内相关系数范围为0.74至0.98,中位数为0.75。尿液半衰期估计值存在一个小但一致的偏差,偏向较短时间;在血浆-尿液研究中,平均偏差为0.75小时,在唾液-尿液研究中为0.192小时。在我们的一名接受多次重组β-干扰素治疗的受试者中,血浆和尿液中安替比林半衰期的估计值出现了平行变化,在研究期间安替比林半衰期增加了150%。

相似文献

1
Plasma antipyrine half-life can be determined from urine data.血浆安替比林半衰期可根据尿液数据来确定。
Br J Clin Pharmacol. 1987 Jun;23(6):715-9. doi: 10.1111/j.1365-2125.1987.tb03106.x.
2
Antipyrine: radioimmunoassay in plasma and saliva following administration of a high dose and a low dose.
Clin Pharmacol Ther. 1976 Aug;20(2):219-26. doi: 10.1002/cpt1976202219.
5
Assessment of antipyrine kinetics by measurement in saliva.通过唾液测量评估安替比林动力学。
Br J Clin Pharmacol. 1976 Apr;3(2):321-5. doi: 10.1111/j.1365-2125.1976.tb00610.x.
8
Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man.
Eur J Clin Pharmacol. 1976 Feb 6;9(4):327-32. doi: 10.1007/BF00561668.
9
Assessment of antipyrine kinetics from saliva or plasma: influence of age.
J Pharm Biomed Anal. 1995 Aug;13(9):1141-5. doi: 10.1016/0731-7085(95)01531-o.
10
Multiple dose pharmacokinetics of ketoconazole and their effects on antipyrine kinetics in man.
J Antimicrob Chemother. 1983 Aug;12(2):185-8. doi: 10.1093/jac/12.2.185.

引用本文的文献

本文引用的文献

4
Measurement of antipyrine half-life from urinary drug concentrations.通过尿药浓度测定安替比林半衰期。
Br J Clin Pharmacol. 1984 Oct;18(4):650-2. doi: 10.1111/j.1365-2125.1984.tb02524.x.
8
Assessment of antipyrine kinetics by measurement in saliva.通过唾液测量评估安替比林动力学。
Br J Clin Pharmacol. 1976 Apr;3(2):321-5. doi: 10.1111/j.1365-2125.1976.tb00610.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验